FDA Alert Warns of Serious Intestinal Problems from Benicar, Azor and Tribenzor

Toledo, OH (PRWEB) July 08, 2014 The U.S. Food and Drug Administration (FDA) issued a warning on July 3, 2013, that the blood pressure drug, olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause serious intestinal problems known as sprue-like enteropathy. The FDA also required changes to the labels of these […]